US 10675271
Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy
granted A61KA61K2300/00A61K31/4168
Quick answer
US patent 10675271 (Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy) held by Monopar Therapeutics Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Monopar Therapeutics Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2300/00, A61K31/4168, A61K45/06, A61P